ArticleCancers2020

HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line.

Hye Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.